Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina Faso

Inclusion Criteria: * Weight \> 5 kg; * Monoinfection with P. falciparum and a parasitaemia of 2,000-200,000 parasites /µl; * Fever (axillary temperature ≥37.5 °C) or history of fever in the preceding 24 hours; * Haemoglobin value above 5.0 g/dl; * Absence of febrile conditions caused by diseases other than malaria. Exclusion Criteria: * Danger signs: not able to drink or breast-feed, vomiting (\> twice in 24hours), recent history of convulsions (\>1 in 24h), unconscious state, unable to sit or stand; * Signs of severe malaria (WHO 2000); * Mixed malaria infection; * Severe malnutrition; * Other underlying diseases (cardiac, renal, hepatic diseases); * History of allergy to study drugs;